162 related articles for article (PubMed ID: 18387656)
1. The long-term prognostic value of multiple biomarkers following a myocardial infarction.
Brügger-Andersen T; Aarsetøy H; Grundt H; Staines H; Nilsen DW
Thromb Res; 2008; 123(1):60-6. PubMed ID: 18387656
[TBL] [Abstract][Full Text] [Related]
2. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
5. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
[TBL] [Abstract][Full Text] [Related]
6. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
[TBL] [Abstract][Full Text] [Related]
7. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
12. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
15. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Blankenberg S; McQueen MJ; Smieja M; Pogue J; Balion C; Lonn E; Rupprecht HJ; Bickel C; Tiret L; Cambien F; Gerstein H; Münzel T; Yusuf S;
Circulation; 2006 Jul; 114(3):201-8. PubMed ID: 16831981
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
[TBL] [Abstract][Full Text] [Related]
17. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.
Bazzino O; Fuselli JJ; Botto F; Perez De Arenaza D; Bahit C; Dadone J;
Eur Heart J; 2004 May; 25(10):859-66. PubMed ID: 15140534
[TBL] [Abstract][Full Text] [Related]
18. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A
Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
[TBL] [Abstract][Full Text] [Related]
19. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.
Vergès B; Zeller M; Beer JC; Cottin Y;
Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]